The first drug that slows Alzheimer's has finally received FDA approval
 

Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.

https://www.engadget.com/the-first-d...2.html?src=rss